Genturi

Genturi is a life sciences technology company specializing in high-throughput genomic mapping to characterize large-scale structural variations in the genome. The company's core technology utilizes a proprietary nanofluidic platform designed to linearize and image ultra-long DNA molecules with high precision. This approach enables the detection of complex genomic rearrangements, such as inversions, translocations, and copy number variations, which are often difficult to resolve using standard short-read sequencing. Genturi's platform is aimed at providing researchers and clinicians with a more complete picture of the genome, particularly in the fields of oncology and rare genetic diseases. By streamlining the analysis of the genome's structural "dark matter," the company seeks to improve diagnostic yields and accelerate the discovery of new biomarkers.